Announcement under Regulation 30 (LODR)-Credit Rating 24 Sep - CRISIL reaffirms AA+/Positive and A1+ ratings for ₹2,050 crore, ₹3,920 crore and proposed ₹4,323.56 crore facilities.
Source: Bse
Chemicals stocks · Small cap · NSE
Chambal Fertilizers & Chemicals Ltd (CFCL) is India's largest private-sector Urea manufacturer with 3.4 MMTPA capacity across three energy-efficient plants in Rajasthan. It offers a single-window agri-solution, marketing complex fertilizers, crop protection chemicals, speciality nutrients, biologicals, and seeds. CFCL is commissioning a 2.4 Lakh MTPA Technical Ammonium Nitrate (TAN) plant.
full bear SMA stack · SMA20 -4.7% / mo · MACD − · near 52W low · sector -4.2pp vs Nifty 500 (3M)
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Strong fundamentals, management evidence is still limited to a financial-only Trust Lite signal, but price trend argues for patience. Suitable for staggered entry or watchlist confirmation rather than aggressive buying.
Strong U-Score but weak trend: timing is not confirming the thesis.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue -11.8% · PAT -4.5% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev -12% YoY · PAT -5% YoY · margin expansion · +81% QoQ · operating leverage
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹5,027 Cr | -11.8% | +80.5% |
| EBITDA | ₹826 Cr | +8.5% | +223.9% |
| Operating margin | 16.0% | +300 bps | +700 bps |
| PAT | ₹524 Cr | -4.5% | +210.1% |
| PAT margin | 10.4% | +79 bps | +435 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 20/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Signals are conflicting — long-term trend down. RSI 35. Wait for confirmation.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 81 · legacy U-Score band DEEP VALUE · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Chemicals — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
FY26 consolidated operational income grew 25% YoY to INR 207,937 Mn, with net profit up 18% YoY to INR 19,533 Mn. Q4-FY26 saw strong YoY growth: operational income +14%, EBITDA +56%, and net profit +30%, though QoQ performance declined significantly due to seasonality.
The company delivered robust FY26 and Q4-FY26 YoY growth in revenue and profit, driven by non-urea segments and new product launches. However, FY26 margins compressed, and trade receivables surged. The TAN plant commissioning is a key diversification, but its ramp-up and impact on financials need close monitoring.
Latest issuer-disclosed distribution across 3 reported categories.
Crop Protection Chemicals and Speciality Nutrients saw 27% YoY contribution growth in FY26, with 17 new products launched and 15 in pipeline for FY27.
Biologicals revenue increased 57% in FY26, with volume up 30%. 'UTTAM PRANAAM' contribution grew 172% in FY26, covering 3 million acres.
Commissioning of the 2.4 Lakh MTPA TAN plant is in progress, diversifying into industrial and mining chemicals with a project cost of INR 16,450 Mn.
The Technical Ammonium Nitrate (TAN) plant, with a capacity of 2.4 Lakh MTPA and project cost of INR 16,450 Mn, is currently in the commissioning phase.
Dry run of the Weak Nitric Acid (WNA) plant, part of the TAN complex, has commenced, to be followed by Ammonium Nitrate Solution Melt and HDAN Solid production.
The TAN initiative aligns with India's 'Aatmanirbhar Bharat' vision, supporting energy security and critical sectors like mining and infrastructure.
Stable demand for urea tied to agricultural cycles and policy pricing, complemented by demand for phosphatic and potassic fertilizers.
Urea volumes were lower in FY26 mainly due to an unscheduled stoppage of one Urea Plant during the year.
FY26 consolidated EBITDA and PAT margins declined YoY despite revenue growth, indicating cost pressures or changes in product mix.
Urea is a highly regulated product, making the business susceptible to policy changes and pricing controls.
A significant increase in standalone trade receivables to INR 20,752 Mn in FY26 from INR 3,679 Mn in FY25 raises concerns about working capital efficiency.
Successful commissioning and ramp-up of the new TAN plant, a large-scale project, is critical for realizing diversification benefits.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
YoY comparison is crucial for assessing annual performance and seasonal business trends in fertilizers. QoQ is important to track sequential momentum, especially given the significant decline in Q4-FY26 consolidated results from Q3-FY26.
FY26 consolidated EBITDA margin was 12.88% (vs 14.92% in FY25), a 14% decline. Q4-FY26 margin was 9.16% (vs 6.67% in Q4-FY25), a 37% increase.
FY26 consolidated PAT margin was 9.39% (vs 9.91% in FY25), a 5% decline. Q4-FY26 margin was 6.08% (vs 5.32% in Q4-FY25), a 14% increase.
Working Capital Days improved to 51 in FY26 from 57 in FY25.
Standalone Trade Receivables increased significantly to INR 20,752 Mn in FY26 from INR 3,679 Mn in FY25.
Activities for commissioning the Technical Ammonium Nitrate plant are in progress, with dry run of WNA plant started.
14 new Crop Protection Chemicals and 1 Speciality Nutrient product are in the pipeline for launch in FY27.
MOU signed for CFCL-TERI Centre of Excellence to develop 10 novel & patented products in Crop Protection and Crop Nutrition over five years.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| TAN Plant Ramp-up | Dry run of WNA plant started. | Production of ANS Melt and HDAN Solid, and commercial sales. |
| Receivables Trend | Standalone Trade Receivables at INR 20,752 Mn; Subsidy Debtors at INR 19,794 Mn. | Reduction in receivables days and improved collection efficiency. |
| Non-Urea Growth | 27% YoY contribution growth in CPC/SN; 57% YoY revenue growth in Biologicals. | Sustained growth rates and successful new product launches in these segments. |
| Overall Margins | FY26 EBITDA margin 12.88% (down 14% YoY); PAT margin 9.39% (down 5% YoY). | Reversal of margin compression trends in subsequent quarters. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 93rd percentile of the scored universe and 89th percentile within Chemicals. No major sub-score weakness stands out.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Chemicals: 89th pctile, median 73 · Small: 95th pctile, median 66
121 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse